Parasites, Hosts and Diseases

The Korea Society for Parasitology and Tropical Medicine (대한기생충학·열대의학회)
권호 표지
DOI QR코드

DOI QR Code

New Molecules in Babesia gibsoni and Their Application for Diagnosis, Vaccine Development, and Drug Discovery

  • Goo, Youn-Kyoung (National Research Center for Protozoan Diseases, Obihiro University of Agriculture and Veterinary Medicine) ;
  • Xuan, Xuenan (National Research Center for Protozoan Diseases, Obihiro University of Agriculture and Veterinary Medicine)
  • Received : 2014.03.04
  • Accepted : 2014.06.24
  • Published : 2014.08.31
Download PDF
⟨ Previous Next ⟩

Abstract

Babesia gibsoni is an intraerythrocytic apicomplexan parasite that causes piroplasmosis in dogs. B. gibsoni infection is characterized clinically by fever, regenerative anemia, splenomegaly, and sometimes death. Since no vaccine is available, rapid and accurate diagnosis and prompt treatment of infected animals are required to control this disease. Over the past decade, several candidate molecules have been identified using biomolecular techniques in the authors' laboratory for the development of a serodiagnostic method, vaccine, and drug for B. gibsoni. This review article describes newly identified candidate molecules and their applications for diagnosis, vaccine production, and drug development of B. gibsoni.

Keywords

References

  1. Groves MG, Yap LF. Babesia gibsoni (Patton, 1910) from a dog in Kuala Lumpur. The Med J Malaya 1968; 22: 229.
  2. Kjemtrup AM, Kocan AA, Whitworth L, Meinkoth J, Birkenheuer AJ, Cummings J, Boudreaux MK, Stockham SL, Irizarry-Rovira A, Conrad PA. There are at least three genetically distinct small piroplasms from dogs. Int J Parasitol 2000; 30: 1501-1505. https://doi.org/10.1016/S0020-7519(00)00120-X
  3. Muhlnickel CJ, Jefferies R, Morgan-Ryan UM, Irwin PJ. Babesia gibsoni infection in three dogs in Victoria. Aust Vet J 2002; 80: 606-610. https://doi.org/10.1111/j.1751-0813.2002.tb10961.x
  4. Baneth G, Breitschwerdt EB, Hegarty BC, Pappalardo B, Ryan J. A survey of tick-borne bacteria and protozoa in naturally exposed dogs from Israel. Vet Parasitol 1998; 74: 133-142. https://doi.org/10.1016/S0304-4017(97)00149-0
  5. Birkenheuer AJ, Correa MT, Levy MG, Breitschwerdt EB. Geographic distribution of babesiosis among dogs in the United States and association with dog bites: 150 cases (2000-2003). J Am Vet Med Assoc 2005; 227: 942-947. https://doi.org/10.2460/javma.2005.227.942
  6. Stegeman JR, Birkenheuer AJ, Kruger JM, Breitschwerdt EB. Transfusion-associated Babesia gibsoni infection in a dog. J Am Vet Med Assoc 2003; 222: 959-963, 952. https://doi.org/10.2460/javma.2003.222.959
  7. Fukumoto S, Suzuki H, Igarashi I, Xuan X. Fatal experimental transplacental Babesia gibsoni infections in dogs. Int J Parasitol 2005; 35: 1031-1035. https://doi.org/10.1016/j.ijpara.2005.03.018
  8. Conrad P, Thomford J, Yamane I, Whiting J, Bosma L, Uno T, Holshuh HJ, Shelly S. Hemolytic anemia caused by Babesia gibsoni infection in dogs. J Am Vet Med Assoc 1991; 199: 601-605.
  9. Boozer AL, Macintire DK. Canine babesiosis. Vet clin North Am Small Anim Pract 2003; 33: 885-904, viii. https://doi.org/10.1016/S0195-5616(03)00039-1
  10. Rosenblatt JE. Laboratory diagnosis of infections due to blood and tissue parasites. Clin Infect Dis 2009; 49: 1103-1108. https://doi.org/10.1086/605574
  11. Yeagley TJ, Reichard MV, Hempstead JE, Allen KE, Parsons LM, White MA, Little SE, Meinkoth JH. Detection of Babesia gibsoni and the canine small Babesia 'Spanish isolate' in blood samples obtained from dogs confiscated from dog fighting operations. J Am Vet Med Assoc 2009; 235: 535-539. https://doi.org/10.2460/javma.235.5.535
  12. Ano H, Makimura S, Harasawa R. Comparison of partial ribosomal DNA sequences of Babesia gibsoni occurring in Miyazaki prefecture, Japan. J Vet Med Sci 2001; 63: 561-562. https://doi.org/10.1292/jvms.63.561
  13. Matsuu A, Ono S, Ikadai H, Uchide T, Imamura S, Onuma M, Okano S, Higuchi S. Development of a SYBR green real-time polymerase chain reaction assay for quantitative detection of Babesia gibsoni (Asian genotype) DNA. J Vet Diagn Invest 2005; 17: 569-573. https://doi.org/10.1177/104063870501700608
  14. Tani H, Tada Y, Sasai K, Baba E. Improvement of DNA extraction method for dried blood spots and comparison of four PCR methods for detection of Babesia gibsoni (Asian genotype) infection in canine blood samples. J Vet Med Sci 2008; 70: 461-467. https://doi.org/10.1292/jvms.70.461
  15. Fritz D. A PCR study of piroplasms in 166 dogs and 111 horses in France (March 2006 to March 2008). Parasitol Res 2010; 106: 1339-1342. https://doi.org/10.1007/s00436-010-1804-3
  16. Zahler M, Schein E, Rinder H, Gothe R. Characteristic genotypes discriminate between Babesia canis isolates of differing vector specificity and pathogenicity to dogs. Parasitol Res 1998; 84: 544-548. https://doi.org/10.1007/s004360050445
  17. Birkenheuer AJ, Levy MG, Breitschwerdt EB. Development and evaluation of a seminested PCR for detection and differentiation of Babesia gibsoni (Asian genotype) and B. canis DNA in canine blood samples. J Clin Microbiol 2003; 41: 4172-4177. https://doi.org/10.1128/JCM.41.9.4172-4177.2003
  18. Ikadai H, Tanaka H, Shibahara N, Matsuu A, Uechi M, Itoh N, Oshiro S, Kudo N, Igarashi I, Oyamada T. Molecular evidence of infections with Babesia gibsoni parasites in Japan and evaluation of the diagnostic potential of a loop-mediated isothermal amplification method. J Clin Microbiol 2004; 42: 2465-2469. https://doi.org/10.1128/JCM.42.6.2465-2469.2004
  19. Irwin PJ. Canine babesiosis: from molecular taxonomy to control. Parasit Vectors 2009; 2 Suppl 1: S4.
  20. Goo YK, Jia H, Aboge GO, Terkawi MA, Kuriki K, Nakamura C, Kumagai A, Zhou J, Lee EG, Nishikawa Y, Igarashi I, Fujisaki K, Xuan X. Babesia gibsoni: Serodiagnosis of infection in dogs by an enzyme-linked immunosorbent assay with recombinant BgTRAP. Exp Parasitol 2008; 118: 555-560. https://doi.org/10.1016/j.exppara.2007.11.010
  21. Goo YK, Jia H, Aboge GO, Terkawi MA, Lee EG, Yamagishi J, Nishikawa Y, Jang HK, Sunaga F, Namikawa K, Fujisaki K, Xuan X. Characterization of the Babesia gibsoni 12-kDa protein as a potential antigen for the serodiagnosis. Parasitol Int 2009; 58: 55-60. https://doi.org/10.1016/j.parint.2008.10.003
  22. Anderson JF, Magnarelli LA, Sulzer AJ. Canine babesiosis: indirect fluorescent antibody test for a North American isolate of Babesia gibsoni. Am J Vet Res 1980; 41: 2102-2105.
  23. Levy MG, Breitschwerdt EB, Moncol DJ. Antibody activity to Babesia canis in dogs in North Carolina. Am J Vet Res 1987; 48: 339-341.
  24. Yamane I, Thomford JW, Gardner IA, Dubey JP, Levy M, Conrad PA. Evaluation of the indirect fluorescent antibody test for diagnosis of Babesia gibsoni infections in dogs. Am J Vet Res 1993; 54: 1579-1584.
  25. Reiter I, Weiland G. Recently developed methods for the detection of babesial infections. Trans R Soc Trop Med Hyg 1989; 83 (suppl): 21-23. https://doi.org/10.1016/0035-9203(89)90598-1
  26. Furuta PI, Oliveira TM, Theixeira MC, Rocha AG, Machado RZ, Tinucci-Costa MG. Comparison between a soluble antigen-based ELISA and IFAT in detecting antibodies against Babesia canis in dogs. Rev Bras Parasitol Vet 2009; 18: 41-45. https://doi.org/10.4322/rbpv.01803007
  27. Bose R, Jorgensen WK, Dalgliesh RJ, Friedhoff KT, de Vos AJ. Current state and future trends in the diagnosis of babesiosis. Vet Parasitol 1995; 57: 61-74. https://doi.org/10.1016/0304-4017(94)03111-9
  28. Wulansari R, Wijaya A, Ano H, Horii Y, Nasu T, Yamane S, Makimura S. Clindamycin in the treatment of Babesia gibsoni infections in dogs. J Am Anim Hosp Assoc 2003; 39: 558-562. https://doi.org/10.5326/0390558
  29. Matsuu A, Koshida Y, Kawahara M, Inoue K, Ikadai H, Hikasa Y, Okano S, Higuchi S. Efficacy of atovaquone against Babesia gibsoni in vivo and in vitro. Vet Parasitol 2004; 124: 9-18. https://doi.org/10.1016/j.vetpar.2004.07.005
  30. Jefferies R, Ryan UM, Jardine J, Robertson ID, Irwin PJ. Babesia gibsoni: detection during experimental infections and after combined atovaquone and azithromycin therapy. Exp Parasitol 2007; 117: 115-123. https://doi.org/10.1016/j.exppara.2007.03.016
  31. Sunaga F, Taharaguchi S, Arai S, Itoh S, Kanno Y. Virulence attenuation of Babesia gibsoni by serial passages in vitro and assessment of the protection provided by the immunization against the passaged isolate in dogs. Vet Parasitol 2013; 197: 565-570. https://doi.org/10.1016/j.vetpar.2013.05.015
  32. Sunaga F, Namikawa K, Kanno Y. Protection of dogs against homologous challenge by the inoculation of irradiated Babesia gibsoni. J Anim Protozooses 2002; 17: 15-18.
  33. Kato S, Ohtoko K, Ohtake H, Kimura T. Vector-capping: a simple method for preparing a high-quality full-length cDNA library. DNA Res 2005; 12: 53-62. https://doi.org/10.1093/dnares/12.1.53
  34. Fukumoto S, Xuan X, Nishikawa Y, Inoue N, Igarashi I, Nagasawa H, Fujisaki K, Mikami T. Identification and expression of a 50-kilodalton surface antigen of Babesia gibsoni and evaluation of its diagnostic potential in an enzyme-linked immunosorbent assay. J Clin Microbiol 2001; 39: 2603-2609. https://doi.org/10.1128/JCM.39.7.2603-2609.2001
  35. Terkawi MA, Zhang G, Jia H, Aboge G, Goo YK, Nishikawa Y, Yokoyama N, Igarashi I, Kawazu SI, Fujisaki K, Xuan X. C3 contributes to the cross-protective immunity induced by Babesia gibsoni phosphoriboprotein P0 against a lethal B. rodhaini infection. Parasite Immunol 2008; 30: 365-370. https://doi.org/10.1111/j.1365-3024.2008.01026.x
  36. Terkawi MA, Jia H, Gabriel A, Goo YK, Nishikawa Y, Yokoyama N, Igarashi I, Fujisaki K, Xuan X. A shared antigen among Babesia species: ribosomal phosphoprotein P0 as a universal babesial vaccine candidate. Parasitol Res 2007; 102: 35-40. https://doi.org/10.1007/s00436-007-0718-1
  37. Terkawi MA, Jia H, Zhou J, Lee EG, Igarashi I, Fujisaki K, Nishikawa Y, Xuan X. Babesia gibsoni ribosomal phosphoprotein P0 induces cross-protective immunity against B. microti infection in mice. Vaccine 2007; 25: 2027-2035. https://doi.org/10.1016/j.vaccine.2006.11.041
  38. Fukumoto S, Xuan X, Inoue N, Igarashi I, Sugimoto C, Fujisaki K, Nagasawa H, Mikami T, Suzuki H. Molecular characterization of a gene encoding a 29-kDa cytoplasmic protein of Babesia gibsoni and evaluation of its diagnostic potentiality. Mol Biochem Parasitol 2003; 131: 129-136. https://doi.org/10.1016/S0166-6851(03)00199-3
  39. Verdida RA, Xuan X, Fukumoto S, Huang X, Zhou J, Igarashi I, Claveria FG, Nagasawa H. Development of a practical immunochromatographic test with recombinant P50 for the diagnosis of Babesia gibsoni infection in dogs. Parasitology 2005; 131: 769-774. https://doi.org/10.1017/S0031182005008401
  40. Jia H, Zhou J, Ikadai H, Matsuu A, Suzuki H, Igarashi I, Fujisaki K, Xuan X. Identification of a novel gene encoding a secreted antigen 1 of Babesia gibsoni and evaluation of its use in serodiagnosis. Am J Trop Med Hyg 2006; 75: 843-850.
  41. Zhou J, Fukumoto S, Jia H, Yokoyama N, Zhang G, Fujisaki K, Lin J, Xuan X. Characterization of the Babesia gibsoni P18 as a homologue of thrombospondin related adhesive protein. Mol Biochem Parasitol 2006; 148: 190-198. https://doi.org/10.1016/j.molbiopara.2006.03.015
  42. Zhou J, Yang J, Zhang G, Nishikawa Y, Fujisaki K, Xuan X. Babesia gibsoni: An apical membrane antigen-1 homologue and its antibody response in the infected dogs. Exp Parasitol 2006; 114: 329-333. https://doi.org/10.1016/j.exppara.2006.04.012
  43. Zhou J, Zhang G, Nishikawa Y, Fujisaki K, Xuan X. A 38-kDa protein from Babesia gibsoni and its antibody response in an experimentally infected dog. Vet Parasitol 2006; 141: 345-348. https://doi.org/10.1016/j.vetpar.2006.05.025
  44. Aboge GO, Jia H, Kuriki K, Zhou J, Nishikawa Y, Igarashi I, Fujisaki K, Suzuki H, Xuan X. Molecular characterization of a novel 32-kDa merozoite antigen of Babesia gibsoni with a better diagnostic performance by enzyme-linked immunosorbent assay. Parasitology 2007; 134: 1185-1194. https://doi.org/10.1017/S0031182007002594
  45. Jia H, Liao M, Lee E, Nishikawa Y, Inokuma H, Ikadai H, Matsuu A, Igarashi I, Xuan X. Development of an immunochromatographic test with recombinant BgSA1 for the diagnosis of Babesia gibsoni infection in dogs. Parasitol Res 2007; 100: 1381-1384. https://doi.org/10.1007/s00436-006-0392-8
  46. Zhou J, Jia H, Nishikawa Y, Fujisaki K, Xuan X. Babesia gibsoni rhoptry-associated protein 1 and its potential use as a diagnostic antigen. Vet Parasitol 2007; 145: 16-20. https://doi.org/10.1016/j.vetpar.2006.10.022
  47. Aboge GO, Jia H, Terkawi MA, Goo Y, Kuriki K, Nishikawa Y, Igarashi I, Suzuki H, Xuan X. A novel 57-kDa merozoite protein of Babesia gibsoni is a prospective antigen for diagnosis and serosurvey of canine babesiosis by enzyme-linked immunosorbent assay. Vet Parasitol 2007; 149: 85-94. https://doi.org/10.1016/j.vetpar.2007.06.025
  48. Jia H, Terkawi MA, Aboge GO, Goo YK, Zhou J, Lee EG, Nishikawa Y, Igarashi I, Fujisaki K, Xuan X. Babesia gibsoni: identification of an immunodominant, interspersed repeat antigen. Exp Parasitol 2008; 118: 146-149. https://doi.org/10.1016/j.exppara.2007.07.005
  49. Fukumoto S, Tamaki Y, Igarashi I, Suzuki H, Xuan X. Immunogenicity and growth inhibitory efficacy of the prime-boost immunization regime with DNA followed by recombinant vaccinia virus carrying the P29 gene of Babesia gibsoni in dogs. Exp Parasitol 2009; 123: 296-301. https://doi.org/10.1016/j.exppara.2009.08.012
  50. Jia H, Terkawi MA, Aboge GO, Goo YK, Ma L, Zhou J, Nishikawa Y, Igarashi I, Fujisaki K, Xuan X. Identification of secreted antigen 3 from Babesia gibsoni. Clin Vaccine Immunol 2009; 16: 944-948. https://doi.org/10.1128/CVI.00087-09
  51. Goo YK, Jia H, Terkawi MA, Aboge GO, Yamagishi J, Nishikawa Y, Kim S, Jang HK, Fujisaki K, Xuan X. Babesia gibsoni: identification, expression, localization, and serological characterization of a Babesia gibsoni 22-kDa protein. Exp Parasitol 2009; 123: 273-276. https://doi.org/10.1016/j.exppara.2009.07.017
  52. Goo YK, Lee N, Terkawi MA, Luo Y, Aboge GO, Nishikawa Y, Suzuki H, Kim S, Xuan X. Development of a rapid immunochromatographic test using a recombinant thrombospondin-related adhesive protein of Babesia gibsoni. Vet Parasitol 2012; 190: 595-598. https://doi.org/10.1016/j.vetpar.2012.06.024
  53. Aboge GO, Batbaatar V, Goo YK, Yamagishi J, Nishikawa Y, Sunaga F, Namikawa K, Igarashi I, Fujisaki K, Suzuki H, Xuan X. Molecular characterization and expression of a 47-kDa merozoite surface protein of Babesia gibsoni for serodiagnosis by enzyme-linked immunosorbent assay. J Protozool Res 2010; 20: 59-69.
  54. Goo YK, Jia H, Aboge GO, Terkawi MA, Yamagishi J, Nishikawa Y, Igarashi I, Xuan X. Identification of an immunodominant Babesia gibsoni 47-kDa antigen. J Protozool Res 2009; 19: 16-21.
  55. Mousa AA, Cao S, Aboge GO, Terkawi MA, Kirdasy AE, Salama A, Attia M, Aboulaila M, Zhou M, Kamyingkird K, Moumouni PF, Masatani T, El Aziz SA, Moussa WM, Chahan B, Fukumoto S, Nishikawa Y, El Ballal SS, Xuan X. Molecular characterization and antigenic properties of a novel Babesia gibsoni glutamic acid-rich protein (BgGARP). Exp Parasitol 2013; 135: 414-420. https://doi.org/10.1016/j.exppara.2013.08.005
  56. Fukumoto S, Tamaki Y, Okamura M, Bannai H, Yokoyama N, Suzuki T, Igarashi I, Suzuki H, Xuan X. Prime-boost immunization with DNA followed by a recombinant vaccinia virus expressing P50 induced protective immunity against Babesia gibsoni infection in dogs. Vaccine 2007; 25: 1334-1341. https://doi.org/10.1016/j.vaccine.2006.09.083
  57. Cao S, Mousa AA, Aboge GO, Kamyingkird K, Zhou M, Moumouni PFA, Terkawi MA, Masatani T, Nishikawa Y, Suzuki H, Fukumoto S, Xuan X. Prime-boost vaccination with plasmid DNA followed by recombinant vaccinia virus expressing BgGARP induced a partial protective immunity to inhibit Babesia gibsoni proliferation in dogs. Acta Parasitol 2013; 58: 619-623.
  58. Aboge GO, Jia H, Terkawi MA, Goo YK, Nishikawa Y, Sunaga F, Namikawa K, Tsuji N, Igarashi I, Suzuki H, Fujisaki K, Xuan X. Cloning, expression, and characterization of Babesia gibsoni dihydrofolate reductase-thymidylate synthase: inhibitory effect of antifolates on its catalytic activity and parasite proliferation. Antimicrob Agents Chemother 2008; 52: 4072-4080. https://doi.org/10.1128/AAC.00384-08
  59. Jia H, Terkawi MA, Aboge GO, Goo YK, Luo Y, Li Y, Yamagishi J, Nishikawa Y, Igarashi I, Sugimoto C, Fujisaki K, Xuan X. Characterization of a leucine aminopeptidase of Babesia gibsoni. Parasitology 2009; 136: 945-952. https://doi.org/10.1017/S0031182009006398
  60. Cao S, Aboge GO, Terkawi MA, Zhou M, Luo Y, Yu L, Goo Y, Kamyingkird K, Masatani T, Suzuki H, Igarashi I, Nishikawa Y, Xuan X. Cloning, characterization and validation of inosine 5'-monophosphate dehydrogenase of Babesia gibsoni as molecular drug target. Parasitol Int 2013; 62: 87-94. https://doi.org/10.1016/j.parint.2012.10.005
  61. Masatani T, Asada M, Ichikawa-Seki M, Usui M, Terkawi MA, Hayashi K, Kawazu S, Xuan X. Cloning and Characterization of a 2-Cys Peroxiredoxin from Babesia gibsoni. J Vet Med Sci 2014; 76: 139-143. https://doi.org/10.1292/jvms.13-0274
  62. Larsen MV, Lundegaard C, Lamberth K, Buus S, Lund O, Nielsen M. Large-scale validation of methods for cytotoxic T-lymphocyte epitope prediction. BMC bioinformatics. 2007; 8: 424. https://doi.org/10.1186/1471-2105-8-424
  63. El-Manzalawy Y, Dobbs D, Honavar V. Predicting linear B-cell epitopes using string kernels. J Mol Recognit 2008; 21: 243-255. https://doi.org/10.1002/jmr.893
  64. EL-Manzalawy Y, Dobbs D, Honavar V. Predicting MHC-II binding affinity using multiple instance regression. IEEE/ACM Trans Comput Biol Bioinform 2011; 8: 1067-1079. https://doi.org/10.1109/TCBB.2010.94
  65. Narantsatsral S, Goo YK, Battsetseg B, Myagmarsuren P, Terkawi MA, Soma T, Luo Y, Li Y, Cao S, Yu L, Kamyingkird K, Aboge GO, Nishikawa Y, Xuan X. Expression of truncated Babesia gibsoni thrombospondin-related adhesive proteins in Escherichia coli and evaluation of their diagnostic potential by enzyme-linked immunosorbent assay. Exp Parasitol 2011; 129: 196-202. https://doi.org/10.1016/j.exppara.2011.07.011
  66. Fukumoto S, Xuan X, Kadota K, Igarashi I, Sugimoto C, Fujisaki K, Nagasawa H, Mikami T, Suzuki H. High-level expression of truncated surface antigen P50 of Babesia gibsoni in insect cells by baculovirus and evaluation of its immunogenicity and antigenicity. Clin Diagn Lab Immunol 2003; 10: 596-601.
  67. Konishi K, Sakata Y, Miyazaki N, Jia H, Goo YK, Xuan X, Inokuma H. Epidemiological survey of Babesia gibsoni infection in dogs in Japan by enzyme-linked immunosorbent assay using B. gibsoni thrombospondin-related adhesive protein antigen. Vet Parasitol 2008; 155: 204-208. https://doi.org/10.1016/j.vetpar.2008.04.025
  68. Terkawi MA, Aboge G, Jia H, Goo YK, Ooka H, Yamagishi J, Nishikawa Y, Yokoyama N, Igarashi I, Kawazu SI, Fujisaki K, Xuan X. Molecular and immunological characterization of Babesia gibsoni and Babesia microti heat shock protein-70. Parasite Immunol 2009; 31: 328-340. https://doi.org/10.1111/j.1365-3024.2009.01109.x
  69. Goo YK, Aboge GO, Terkawi MA, Jia H, Yamagishi J, Sunaga F, Namikawa K, Cha SY, Jang HK, Kim S, Nishikawa Y, Xuan X. Four promising antigens, BgP32, BgP45, BgP47, and BgP50, for serodiagnosis of Babesia gibsoni infection were classified as B. gibsoni merozoite surface protein family. Parasitol Int 2012; 61: 364-368. https://doi.org/10.1016/j.parint.2011.11.007
  70. Fukumoto S, Tamaki Y, Shirafuji H, Harakawa S, Suzuki H, Xuan X. Immunization with recombinant surface antigen P50 of Babesia gibsoni expressed in insect cells induced parasite growth inhibition in dogs. Clin Diagn Lab Immunol 2005; 12: 557-559.
  71. Fukumoto S, Xuan X, Takabatake N, Igarashi I, Sugimoto C, Fujisaki K, Nagasawa H, Mikami T, Suzuki H. Inhibitory effect of antiserum to surface antigen P50 of Babesia gibsoni on growth of parasites in severe combined immunodeficiency mice given canine red blood cells. Infect Immun 2004; 72: 1795-1798. https://doi.org/10.1128/IAI.72.3.1795-1798.2004
  72. Aboge GO, Jia H, Terkawi MA, Goo YK, Batbaatar V, Nishikawa Y, Sunaga F, Namikawa K, Fujisaki K, Suzuki H, Xuan X. Precursors of methotrexate target dihydrofolate reductase-thymidylate synthase of Babesia gibsoni and inhibit parasite proliferation. J Protozool Res 2010; 20: 70-81.
  73. Ginsburg H. Metabolism: Malaria parasite stands out. Nature 2010; 466: 702-703. https://doi.org/10.1038/466702a
  74. Cao S, Aboge GO, Terkawi MA, Zhou M, Kamyingkird K, Moumouni PFA, Masatani T, Igarashi I, Nishikawa Y, Suzuki H, Xuan X. Mycophenolic acid, mycophenolate mofetil, mizoribine, ribavirin, and 7-nitroindole inhibit propagation of Babesia parasites by targeting inosine 5'-monophosphate dehydrogenase. J Parasitol 2014 (in press). doi: http://dx.doi.org/10.1645/13-278.1.

Cited by

  1. Establishment of a stable transfection system for genetic manipulation of Babesia gibsoni vol.11, pp.1, 2018, https://doi.org/10.1186/s13071-018-2853-1
  2. Two Imported Cases of Babesiosis with Complication or Co-Infection with Lyme Disease in Republic of Korea vol.56, pp.6, 2014, https://doi.org/10.3347/kjp.2018.56.6.609
  3. Babesia gibsoni endemic to Wuhan, China: mitochondrial genome sequencing, annotation, and comparison with apicomplexan parasites vol.118, pp.1, 2014, https://doi.org/10.1007/s00436-018-6158-2
  4. Evaluation of Babesia gibsoni GPI-anchored Protein 47 (BgGPI47-WH) as a Potential Diagnostic Antigen by Enzyme-Linked Immunosorbent Assay vol.6, pp.None, 2019, https://doi.org/10.3389/fvets.2019.00333
  5. Babesia canis spp. in dogs in Baghdad Province, Iraq: First molecular identification and clinical and epidemiological study vol.13, pp.3, 2014, https://doi.org/10.14202/vetworld.2020.579-585
  6. Survey and Molecular Study of Babesia gibsoni in Dogs of Baghdad Province, Iraq vol.44, pp.no.e, 2020, https://doi.org/10.30539/ijvm.v44i(e0).1019
  7. The Infection and Species Identification of Canine Babesia spp. in Parts of Shaanxi Province vol.107, pp.5, 2021, https://doi.org/10.1645/19-177
  8. In vitro screening of novel anti-Babesia gibsoni drugs from natural products vol.85, pp.None, 2014, https://doi.org/10.1016/j.parint.2021.102437